Pharming Group NVPHARM
± MixedCapitalrelevance
Earnings call held but no figures disclosed; impact unclear.
Impact on stocks 1
Biotech & Genomic Medicine
Pharming Group NVPharming Group N.V. held its second-quarter 2026 earnings conference call. The call featured prepared remarks from company executives followed by a question-and-answer session with analysts. No specific financial figures or forward-looking statements were disclosed in the transcript provided.
Pharming Group NVEarnings call held but no figures disclosed; impact unclear.